Home > Insider Trading > Filing (0000899243-19-026127)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
313143	Haemonetics Corp	HAE	Surgical & Medical Instruments & Apparatus (3841)	042882273

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1682069	Mr. P. William Burke	400 Wood Road Braintree MA 02184	Evp, Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-10-25	11,231	$34.21	24,245	No	4	M	Direct
Common Stock	Disposition	2019-10-25	6,905	$119.87	17,340	No	4	S	Direct
Common Stock	Disposition	2019-10-25	4,326	$120.65	13,014	No	4	S	Direct
Common Stock	Disposition	2019-10-28	1,155	$120.33	11,859	No	4	S	Direct
Common Stock	Disposition	2019-10-29	1,448	$122.69	10,411	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified Stock Option (Right to Buy)	Disposition	2019-10-25	11,231	$0.00	11,231	$34.21

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,232	2019-10-25	2023-10-25	No	4	M	Direct

Footnotes

Transaction pursuant to an existing 10b5-1 trading plan.
This number includes unvested restricted stock units previously reported.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.38 to $120.35, inclusive. the reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging form $120.38 to $120.97, inclusive.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.